Mixed Protamine Zinc Recombinant Insulin Lispro Injection(50R/25R)（Fosun Pharma）

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMixed Protamine Zinc Recombinant Insulin Lispro Injection(50R/25R)（Fosun Pharma）
Drug Alias Name精蛋白锌重组赖脯胰岛素混合注射液(50R/25R)
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin ligandInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesFosun Holdings Ltd
China Registration ClassN/A

Develop Information

Active CompaniesFosun Holdings Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A